April 2014 FDA Recall Pristiq by Pfizer Us Pharmaceutical Group
D-1409-2014 - Presence of Foreign Tablets/Capsules

This Class II drug recall was voluntarily initiated by Pfizer Us Pharmaceutical Group on April 16, 2014 for the product Pristiq. The FDA reported the reason for recall as presence of foreign tablets/capsules. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1409-2014

Reason for Recall
Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.
Initiated
04-16-2014
Reported
07-02-2014
Quantity
220,761 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Pfizer Us Pharmaceutical Group
Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc., NDC 0008-1211-30

Batch or Lot Expiration Information

Lot# H74477, H74478, Exp. 03/16, H74479, H79766 Exp. 05/16